Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
65
Sex
Women only
Ages
Ages 35 Years to 65 Years
Primary completion
2025-04-01
Last update
2025-05-06

What this trial studies

This will be a randomized study to determine if animal-based protein-rich food sources can stimulate greater muscle protein turnover and whole-body protein balance and reduce skeletal muscle inflammatory markers in postmenopausal women compared to vegetarian base protein-rich foods.

Conditions in scope

  • Menopause Related Conditions

Interventions

  • meals consisting of primarily animal protein sources (Other) — an omnivorous diet
  • meals consisting of plant protein sources (Other) — an herbivorous diet

Who can join

Women only · Ages 35 Years to 65 Years · Accepts healthy volunteers.

Inclusion criteria

  • Postmenopausal women ages 50-65 (absence of menstruation for at least 12 months).
  • Premenopausal women ages 35-45 (presence of normal monthly menstruation for the past 12 months).
  • BMI of 20.0 - 34.9 kg/m2.
  • COVID-19 negative and/or asymptomatic

Exclusion criteria

  • Any substantial musculoskeletal injuries/diseases that have limited daily activities in the past month.
  • Unable to stop the use of anti-inflammatory drugs for the week prior to and during study.
  • Diagnosed metabolic or hormonal disease (i.e., renal, cardiovascular, thyroid, polycystic ovary syndrome, or type I/II diabetes mellitus).
  • Currently pregnant.
  • Gave birth or was lactating within previous 12 months.
  • Undergone gastric bypass/bariatric surgery.
  • Clinically significant weight gain or loss (\>5% change) in the last 12 months.
  • Consuming metabolism-altering drugs or medications (i.e., corticosteroids, stimulants, insulin, thyroid medication).

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

CityState / RegionFacilitySite status
Little Rock Arkansas Center of Translational Research in Aging and Longevity Unknown

Status & timeline

  • Overall status: Completed
  • Study type: Interventional
  • Phase: N/A
  • Start date: 2023-08-28
  • Primary completion: 2025-04-01
  • Last update posted: 2025-05-06
  • First posted: 2023-02-06

Lead sponsor: University of Arkansas (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

  • Net change in muscle protein synthesis (% per day). (Study meals are eaten for 5 consecutive days.)
    Change in net muscle protein synthesis between groups.

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.

Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT05714462 before contacting a site.

ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.